Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sani H Kizilbash
Mayo Clinic Cancer Center LAO
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Sibley Memorial Hospital
Washington D.C., District of Columbia, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Laura and Isaac Perlmutter Cancer Center at Nyu Langone
New York, New York, United States
- Nyp/columbia University Medical Center/herbert Irving Comprehensive Cancer Center
New York, New York, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Ut Md Anderson Cancer Center
Houston, Texas, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- University of Virginia Cancer Center
Charlottesville, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 May 2019
- Primary completion
- 11 Sept 2026
- Completion
- 11 Sept 2026
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 40
- Registry id
- NCT03528642
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.